Android app Apple app link

ResMed Inc. (RMD) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$246.17
Day's range
$253.13

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/30/2026 Mizuho Securities Anthony Petrone $270.00 $252.83   6.79%
10/13/2026 Mizuho Securities Anthony Petrone $240.00 $234.60   2.3%
09/15/2026 RBC Capital Craig Wong-Pan $262.00 $222.99   17.49%
07/21/2026 UBS David Low $300.00 $195.97   53.08%
06/17/2026 Morgan Stanley David Bailey $230.00 $193.94   18.59%
04/13/2026 Evercore ISI Anthony Petrone $255.00 $228.33   11.68%
01/30/2026 RBC Capital Craig Wong-Pan $314.00 $254.08   23.58%
01/30/2026 KeyBanc Brett Fishbin $302.00 $257.61   17.23%
12/18/2025 Stifel Nicolaus Jonathan Block $260.00 $245.94   5.72%
12/12/2025 UBS Marcus Curley $345.00 $251.38   37.25%
10/31/2025 KeyBanc Brett Fishbin $299.00 $244.12   22.48%
10/31/2025 Morgan Stanley David Bailey $305.00 $252.26   20.91%
05/20/2025 Morgan Stanley David Bailey $286.00 $248.14   15.26%
04/24/2025 KeyBanc Brett Fishbin $274.00 $232.65   17.77%
04/16/2025 Mizuho Securities Anthony Petrone $265.00 $211.49   25.3%
01/31/2025 Piper Sandler Adam Maeder $260.00 $236.18   10.09%
12/12/2024 Stifel Nicolaus Jonathan Block $250.00 $242.51   3.09%
10/01/2024 RBC Capital Craig Wong-Pan $224.00 $238.95   -6.26%
09/23/2024 Robert W. Baird Joe Vruwink $280.00 $246.18   13.74%
09/17/2024 Wolfe Research Mike Polark $180.00 $250.88   -28.25%
04/10/2024 RBC Capital Craig Wong-Pan $187.00 $194.27   -3.74%
04/01/2024 Stifel Nicolaus Mike Matson $224.00 $198.03   13.11%
10/27/2023 Oppenheimer Suraj Kalia $175.00 $134.65   29.97%
09/06/2023 Needham Mike Matson $180.00 $153.89   16.97%
10/13/2021 Oppenheimer Suraj Kalia $312.00 $253.77   22.95%
08/03/2021 Morgan Stanley Sean Laaman $250.00 $271.87   -8.04%
07/27/2021 Jefferies Anthony Petrone $240.00 $264.75   -9.35%

Resmed Inc. FAQ's

Resmed Inc. has been rated by research analysts at Mizuho Securities, RBC Capital, KeyBanc, Redburn Partners, Robert W. Baird, UBS in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.